Skip to content
healthcare.dev

BARACLUDE

NDC 0003-1614, entecavir, solution, from E.R. Squibb & Sons, L.L.C..

Product NDC
0003-1614
Status
Listed
Labeler
E.R. Squibb & Sons, L.L.C.
Dosage form
SOLUTION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA021798
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0003-1614 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ENTECAVIR.05 mg/mL

Pharmacologic classes

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Nucleoside Analog [EXT]; Nucleoside Reverse Transcriptase Inhibitors [MoA]

Package NDCNDC-11Package
0003-1614-12000031614121 BOTTLE in 1 CARTON (0003-1614-12) / 210 mL in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/046e61c9-9298-4b2e-b76e-b26b81fecd20

Use it

Look up 0003-1614 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0003-1614 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0003-1614. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.